Amennai Beyeen
Analyst-Equity at Rhenman & Partners Asset Management AB
Profile
Dr. Amennai Beyeen is an Analyst at Rhenman & Partners Asset Management AB.
He has15 years of experience in medical positions within the life science industry.
Dr. Beyeen was previously employed as a Principal by Novartis Pharma (Sweeden) and a Principal by GlaxoSmithKline AB.
He received his graduate degree from Karolinska Institutet and a doctorate degree from Karolinska Institutet.
Amennai Beyeen active positions
Companies | Position | Start |
---|---|---|
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Analyst-Equity | 2023-03-31 |
Former positions of Amennai Beyeen
Companies | Position | End |
---|---|---|
Novartis Pharma (Sweeden) | Corporate Officer/Principal | 2023-03-31 |
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Corporate Officer/Principal | 2005-06-30 |
Training of Amennai Beyeen
Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Finance |
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Health Technology |
Novartis Pharma (Sweeden) |
- Stock Market
- Insiders
- Amennai Beyeen